NeuroPace Q3 revenue $21.1M (+28% YoY); raises FY2024 guidance to $78-80M

NeuroPace Inc

2024-Q3 EPS reported -$0.76 revenue$58,440,000

Record quarterly revenue $21.1M vs $16.4M Q3 2023, driven by RNS System sales.
Net loss narrowed to $5.5M ($0.22 EPS) from $7.3M; operating loss $4.2M vs $6.0M.
Cash burn reduced to $1.8M from $2.3M; cash & investments $56.8M at quarter end.
Full-year 2024 revenue guidance raised to $78-80M (19-22% growth); gross margin guided 72-74%.
Appointed Brett Wingeier VP R&D, Katie Keller VP Marketing, Amy Treadwell VP HR.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.